Caki-1/oe-ZNF268 cells were injected in the flank of NOD-SCID mice, and tumor volume was recorded every three days with the lower proliferation curve of OE-ZNF268 indicating the effective anti-tumor performances (Figure 3b). This evidence concerns the gene ZNF268 and neoplasm.